 | Zacks Investment Research Upgrades Albireo Pharma (NASDAQ:ALBO) to "Hold"
marketbeat.com - February 17 at 3:47 PM |
 | Jan Mattsson Sells 31,470 Shares of Albireo Pharma, Inc. (NASDAQ:ALBO) Stock
americanbankingnews.com - March 3 at 9:08 PM |
| Albireo Pharma, Inc. (NASDAQ:ALBO) to Post Q1 2021 Earnings of ($1.66) Per Share, Piper Sandler Forecasts
americanbankingnews.com - March 3 at 8:07 AM |
| Albireo Pharma (NASDAQ:ALBO) Stock Price Up 6.8% Following Analyst Upgrade
americanbankingnews.com - March 1 at 6:14 PM |
| Albireo Pharma (NASDAQ:ALBO) Price Target Raised to $81.00
americanbankingnews.com - March 1 at 10:59 AM |
| Analyzing Eli Lilly and (NYSE:LLY) and Albireo Pharma (NASDAQ:ALBO)
americanbankingnews.com - March 1 at 9:38 AM |
| Robert W. Baird Reiterates "Buy" Rating for Albireo Pharma (NASDAQ:ALBO)
americanbankingnews.com - March 1 at 9:05 AM |
 | Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 27 at 9:47 AM |
 | Industry Analysts Just Made A Captivating Upgrade To Their Albireo Pharma, Inc. (NASDAQ:ALBO) Revenue Forecasts
finance.yahoo.com - February 27 at 9:47 AM |
| Albireo Pharma (NASDAQ:ALBO) Issues Earnings Results
americanbankingnews.com - February 26 at 5:16 PM |
|
| Albireo Spotlights Global Patient Communities on Rare Disease Day
finance.yahoo.com - February 26 at 9:05 AM |
 | Albireo Pharma, Inc. (ALBO) Q4 2020 Earnings Call Transcript
msn.com - February 26 at 12:40 AM |
| Albireo Pharma, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 25 at 4:07 PM |
| Albireo Reports Q4 and Year-End 2020 Financial Results and Business Update
finance.yahoo.com - February 25 at 9:39 AM |
| Albireo to Participate in Cowen and H.C. Wainwright Global Investor Conferences
finance.yahoo.com - February 23 at 9:34 AM |
| Albireo Pharma (ALBO) Scheduled to Post Earnings on Thursday
americanbankingnews.com - February 19 at 10:44 AM |
| Albireo to Report Q4 and Year-End 2020 Financial Results on February 25
finance.yahoo.com - February 18 at 8:46 AM |
| Did Albireo Pharma's (NASDAQ:ALBO) Share Price Deserve to Gain 81%?
finance.yahoo.com - February 5 at 10:21 AM |
| Albireo Pharma: De-Risked Small-Cap Biotech Ready For Commercialization
seekingalpha.com - January 27 at 7:12 AM |
| Albireo to Participate in H.C. Wainwright BioConnect and LifeSci Advisors Investor Conferences
finance.yahoo.com - January 5 at 8:58 AM |
| Is ALBO A Good Stock To Buy Now?
finance.yahoo.com - December 19 at 6:54 PM |
| Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome
finance.yahoo.com - December 17 at 9:38 AM |
| Albireo Submits for U.S. FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC
finance.yahoo.com - December 8 at 4:39 PM |
 | The Petri Dish: Wyss Institute's VC partnership and a health tech firm eyes M&A
bizjournals.com - November 19 at 8:09 AM |
| Albireo Pharma's odevixibat shows durable response in a rare pediatric liver disease
seekingalpha.com - November 13 at 9:31 PM |
| Albireo to Participate in Jefferies and Piper Sandler Virtual Investor Conferences
finance.yahoo.com - November 12 at 1:03 PM |
 | The Albireo Pharma, Inc. (NASDAQ:ALBO) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
nasdaq.com - November 7 at 12:42 PM |
| Albireo Pharma, Inc. (NASDAQ:ALBO) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
finance.yahoo.com - November 7 at 7:39 AM |
| Albireo Pharma EPS misses by $0.45, beats on revenue
seekingalpha.com - November 5 at 10:00 AM |
| Albireo Reports Q3 2020 Financial Results and Provides Business Update
finance.yahoo.com - November 5 at 10:00 AM |
|
| Albireo’s Odevixibat PFIC Phase 3 Results Accepted for AASLD Late-Breakers
finance.yahoo.com - November 2 at 12:31 PM |
| Albireo Announces Presentations at NASPGHAN 2020 Annual Meeting
finance.yahoo.com - October 23 at 9:52 AM |
| Insider Buys Albireo Pharma's Shares
finance.yahoo.com - September 15 at 7:31 PM |
 | Insider Buys Albireo Pharma's Shares
benzinga.com - September 15 at 2:30 PM |
| Albireo's Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - September 11 at 7:49 AM |
| Albireo Prices Public Offering of 4,000,000 Shares of Common Stock
finance.yahoo.com - September 10 at 5:32 AM |
| Albireo Announces Proposed Public Offering of 3,000,000 Shares of Common Stock
finance.yahoo.com - September 8 at 6:50 PM |
| Mid-Morning Market Update: Markets Open Lower; Grifols To Buy Geriatric Pharma Startup Alkahest
benzinga.com - September 8 at 1:50 PM |
| Albireo up 10% ahead of late-stage odevixibat data readout
seekingalpha.com - September 8 at 8:49 AM |
| Albireo Phase 3 Trial Meets Both Primary Endpoints for Odevixibat in PFIC
finance.yahoo.com - September 8 at 8:49 AM |
| Is the Options Market Predicting a Spike in Albireo Pharma (ALBO) Stock?
finance.yahoo.com - September 3 at 10:29 AM |
| How Much Of Albireo Pharma, Inc. (NASDAQ:ALBO) Do Institutions Own?
finance.yahoo.com - August 27 at 8:37 AM |
| Albireo (ALBO) Looks Good: Stock Adds 5.1% in Session
finance.yahoo.com - August 21 at 2:22 PM |
| Albireo Down on Unimpressive Data From Mid-Stage NASH Study
finance.yahoo.com - August 19 at 3:16 PM |
| Albireo under pressure on elobixibat strikeout in NASH
seekingalpha.com - August 18 at 5:56 PM |
| Albireo Reports Topline Results from Phase 2 Trial of Elobixibat in NAFLD/NASH
finance.yahoo.com - August 18 at 5:56 PM |
| Albireo Corporate Updates, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - August 10 at 11:43 PM |
| Albireo Pharma, Inc.'s (ALBO) CEO Ron Cooper on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 5:39 PM |
 | Albireo Pharma, Inc. (ALBO) Q2 2020 Earnings Call Transcript
fool.com - August 7 at 6:48 PM |
| Albireo Pharma EPS beats by $0.28, beats on revenue
seekingalpha.com - August 6 at 12:35 PM |
| Albireo Reports Q2 2020 Financial Results and Provides Business Update
finance.yahoo.com - August 6 at 7:35 AM |
